Abstract:Introduction Down syndrome (DS) is a genetic disease caused by a third copy of chromosome 21, leading to various physical features, developmental and cognitive delays and intellectual disability. In neonates, main symptoms concern congenital heart defects, gastrointestinal abnormalities and sleep disordered breathing. A recent retrospective study showed a high prevalence of obstructive sleep apnea (OSA) in children with DS, with severity inversely related with age culminating at 58% of severe OSA in neonates < 1y. Knowing that OSA can cause intermittent hypoxia and hypercapnia and have detrimental effects on health and development, it raises concerns about the impact of OSA on neurodevelopmental disorders associated with DS, especially in neonates. Many animal models exist. Dp(16)1Yey mice, a genetically engineered model, exhibit cognitive impairments and characteristics associated with OSA, including craniofacial hypoplasia and reduced upper airway volume at adult age. To further investigate the contribution of respiratory-related disorders to DS pathophysiology, we examined the respiratory phenotype of Dp(16)1Yey mice at birth, with special attention to central, obstructive and mixed apneas. Methods On the day of birth, the pups' snouts were attached to a pneumotachometer with a polyether adhesive. Abdominal movements were measured using a laser sensor pointing the lateral abdominal wall to detect respiratory efforts and discriminate apnea. The classification into central, obstructive or mixed apneas was performed by visual inspection of pneumotachometer and laser signals. Electrocardiograms (ECG) were recorded using two human skin electrodes adapted to the size of the pups. Heart rate (HR) was determined from the R-R wave peaks after visual selection of continuous, 20-s or longer ECG segments with clearly defined QRS waves. Results At birth, Dp(16)1Yey mouse pups exhibited lower weight and HR compared to their wild type (WT) counterparts. Baseline breathing variables and response to hypercapnia were similar between the two groups. Total time for obstructive apneas was longer in Dp(16)1Yey than in WT pups (2.18 ± 1.8 s/min vs. 1.24 ± 1.6 s/min, respectively; P = 0.023), owing to their longer mean duration (3.11 ± 1.1 s vs. 2.05 ± 0.7 s, respectively; P = 0.002). ECG analysis did not reveal apnea-related bradycardia in either group. Conclusion These findings highlight the relevance of the Dp(16)1Yey model for studying OSA in DS, including its occurrence at birth. This model represents a valuable tool to investigate the contribution of early respiratory disorders to DS pathology and assess safety and efficacy of pharmacological treatments targeting obstructive sleep disordered breathing in DS.

Early detection and treatment of obstructive sleep apnoea in infants with Down syndrome: a prospective, non-randomised, controlled, interventional study

0518 Clinical Correlates, Diagnosis, and Management of Sleep-disordered Breathing in Young Children with Down Syndrome

Validation of a predictive model for obstructive sleep apnea in people with Down syndrome

0795 Quantifying Guideline Adherence: Sleep Testing in the Pediatric down Syndrome Population

Sleep Apnea and Hypoventilation in Patients with Down Syndrome: Analysis of 144 Polysomnogram Studies

OSA type-III and neurocognitive function

Noenatal obstructive sleep apneas in a mouse model of Down syndrome

Age‐Related Clinical and Polysomnographic Features of Severe Obstructive Sleep Apnea in Infants

Role of polysomnography in the management of obstructive sleep apnea during the first year of life in Robin sequence: a prospective and longitudinal study

Contactless sleep monitoring using the Sonomat in children with Down syndrome

Role of upper airway evaluation in the multidisciplinary management of obstructive sleep apnea in children below two years of age

Effect of sleep disordered breathing severity in children with Down syndrome on parental wellbeing and social support

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in a Young Child With Down Syndrome

"Skeletal surgical approach in Down Syndrome with Obstructive Sleep Apnea."

Adolescents and young adults with Down syndrome presenting to a medical clinic with depression: co-morbid obstructive sleep apnea

0772 OSA Improvement Due to Ato-oxy in Children with down Syndrome Predicts Improved Quality of Life

Respiratory and Neurodevelopmental Outcomes at 3 Years of Age of Neonates Diagnosed with Sleep-Disordered Breathing

An update on diagnosis and management of obstructive sleep apnoea in the first 2 years of life

0796 Implementation of the San Diego Sleep Survey (SDSS) in Children with down Syndrome

Obstructive sleep apnea syndrome during the first year of life in Robin sequence RS: a prospective and longitudinal polysomnography PSG study

Sleep Disorders in Adults with Down Syndrome